AWH Aspira Womens Health Inc.

Aspira engages in the provision of bio-analytic and diagnostic services. Its product, OVA1, is a serum test for identifying women of having malignant ovarian tumor. Its bio-analytical solutions helps physicians diagnose, treat, and improve gynecologic health outcomes for women. The company was founded on December 9, 1993 and is headquartered in Austin, TX.

$5.56  -0.10 (-1.77%)
As of 06/22/2021 15:58:58 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Diagnostics & Research
Index country:  USA
Country of incorporation:  USA
IPO date:  07/12/2006
Outstanding shares:  111,946,449
Average volume:  411,362
Market cap:   $631,377,972
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    04537Y109
ISIN:        US04537Y1091
Sedol:      BMVJKX2
Valuation   (See tab for details)
PE ratio:   -31.49
PB ratio:   12.11
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy